← Leaderboards

Jerry D Glickson

University Of Pennsylvania

Google Scholar ↗PubMed ↗ORCID ↗

$20,468,757

Attributed

$24,332,801

Total exposure

21

Grants

8

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY2005–23

$2M$1.5M$1M$500K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

Funding mix

By agency

NIH$24,832,801 · 22

By mechanism

R01$15,436,317 · 8

R24$2,222,190 · 1

U24$2,083,514 · 1

S10$1,499,000 · 6

P20$1,053,567 · 1

P41$958,196 · 2

Top collaborators

Others in their field

Top investigators on “Magnetic Resonance Imaging”

Michael W Weiner · Northern California Institute Res &Educ$151,227,246
Paul S. Aisen · Cognition Therapeutics, Inc.$114,102,468
Reisa A. Sperling · Banner Health$112,709,449
Randall J Bateman · Washington University$108,056,165
Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
Joseph E Robertson · Oregon Health & Science University$93,739,249

Research focus

Magnetic Resonance ImagingResponseTumorGlycolysisDetectionMalignant NeoplasmsCholineNeoplastic CellPharmaceutical PreparationsMonitorImageMelanomaIn VivoBaseLactic AcidCancer CellFundingBioimaging /Biomedical ImagingXenograft ProcedureMetabolicCellsPhysiologic PulseProgramsMeasurement

Grant awards (70)

Metabolic Imaging of Targeted Therapies in Cancer$597,658

R01 · FY2023 · CA

Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition$492,237

R01 · FY2023 · CA

Melanoma: Metabolic Biomarkers of Response to Targeted Therapy$470,275

R01 · FY2023 · CA

Metabolic Imaging of Targeted Therapies in Cancer$625,478

R01 · FY2022 · CA · contact PI

Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition$492,237

R01 · FY2022 · CA · contact PI

Melanoma: Metabolic Biomarkers of Response to Targeted Therapy$470,275

R01 · FY2022 · CA · contact PI

Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition$501,912

R01 · FY2021 · CA · contact PI

Melanoma: Metabolic Biomarkers of Response to Targeted Therapy$479,380

R01 · FY2021 · CA · contact PI

Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition$516,669

R01 · FY2020 · CA · contact PI

Melanoma: Metabolic Biomarkers of Response to Targeted Therapy$478,396

R01 · FY2020 · CA · contact PI

Mechanism of Activity of Lonidamine$542,325

R01 · FY2017 · CA · contact PI

Mechanism of Activity of Lonidamine$542,325

R01 · FY2016 · CA · contact PI

Systemic Chemotherapy of Melanoma: NMR Studies of Lonidamine & N-Mustard Activity$457,728

R01 · FY2016 · CA · contact PI

Mechanism of Activity of Lonidamine$562,245

R01 · FY2015 · CA · contact PI

Systemic Chemotherapy of Melanoma: NMR Studies of Lonidamine & N-Mustard Activity$457,728

R01 · FY2015 · CA · contact PI

Mechanism of Activity of Lonidamine$545,378

R01 · FY2014 · CA · contact PI

Systemic Chemotherapy of Melanoma: NMR Studies of Lonidamine & N-Mustard Activity$443,996

R01 · FY2014 · CA · contact PI

Mechanism of Activity of Lonidamine$567,405

R01 · FY2013 · CA · contact PI

Systemic Chemotherapy of Melanoma: NMR Studies of Lonidamine & N-Mustard Activity$430,265

R01 · FY2013 · CA · contact PI

Systemic Chemotherapy of Melanoma: NMR Studies of Lonidamine & N-Mustard Activity$472,728

R01 · FY2012 · CA · contact PI

1H NMR STUDIES OF NON-HODGKINS LYMPHOMA$358,748

R01 · FY2012 · CA · contact PI

Penn Small Animal Imaging Resource (Penn-SAIR)$346,675

U24 · FY2011 · CA · contact PI

1H NMR STUDIES OF NON-HODGKINS LYMPHOMA$343,695

R01 · FY2011 · CA · contact PI

NMR of Melanoma Acidification, Bioenergetics, Metabolism and Therapeutic Response$466,922

R01 · FY2010 · CA · contact PI

Penn Small Animal Imaging Resource (Penn-SAIR)$442,700

U24 · FY2010 · CA · contact PI

1H NMR STUDIES OF NON-HODGKINS LYMPHOMA$364,626

R01 · FY2010 · CA · contact PI

Small Animal Imaging Core$187,523

P30 · FY2010 · AR · contact PI

NMR of Melanoma Acidification, Bioenergetics, Metabolism and Therapeutic Response$470,517

R01 · FY2009 · CA · contact PI

Penn Small Animal Imaging Resource (Penn-SAIR)$456,252

U24 · FY2009 · CA · contact PI

1H NMR STUDIES OF NON-HODGKINS LYMPHOMA$357,353

R01 · FY2009 · CA · contact PI

Small Animal Imaging Core$189,425

P30 · FY2009 · AR · contact PI

Penn Small Animal Imaging Resource (Penn-SAIR)$457,562

U24 · FY2008 · CA · contact PI

Small Animal Imaging Core$189,916

P30 · FY2008 · AR · contact PI

Penn Small Animal Imaging Resource (Penn-SAIR)$380,325

U24 · FY2007 · CA · contact PI

1H NMR STUDIES OF NON-HODGKINS LYMPHOMA$356,111

R01 · FY2007 · CA · contact PI

Small Animal Imaging Core$133,284

P30 · FY2007 · AR · contact PI

1H NMR STUDIES OF NON-HODGKINS LYMPHOMA$356,823

R01 · FY2006 · CA · contact PI

Small Animal Imaging Core$91,561

P30 · FY2006 · AR · contact PI

Research console for 4T imager$500,000

S10 · FY2005 · RR

1H NMR STUDIES OF NON-HODGKINS LYMPHOMA$355,550

R01 · FY2005 · CA

RESEARCH CONSOLE FOR 4T IMAGER: NEUROSCIENCE$245,000

S10 · FY2005 · RR

RESEARCH CONSOLE FOR 4T IMAGER: CANCER$110,000

S10 · FY2005 · RR

RESEARCH CONSOLE FOR 4T IMAGER: ARTHRITIS$75,000

S10 · FY2005 · RR

RESEARCH CONSOLE FOR 4T IMAGER: IMAGING$70,000

S10 · FY2005 · RR

1H NMR STUDIES OF NON-HODGKINS LYMPHOMA$345,974

R01 · FY2004 · CA

SMALL ANIMAL MULTI-MODALITY IMAGING CENTER (SAMMIC)$577,988

R24 · FY2003 · CA

SMALL ANIMAL MULTI-MODALITY IMAGING CENTER (SAMMIC)$562,734

R24 · FY2002 · CA

MID-ATLANTIC IN VIVO CELLULAR &MOLECULAR IMAGING CENTER$253,567

P20 · FY2002 · CA

USE OF NMR TO MEASURE TUMOR AND NORMAL TISSUE METAB DURING TUMOR ACIDIFICATION$228,401

P01 · FY2002 · CA

USE OF NMR TO MEASURE TUMOR AND NORMAL TISSUE METAB DURING TUMOR ACIDIFICATION$228,401

P01 · FY2002 · CA

MRS TO MONITOR GLUCURONIDASE ACTIVITY IN CYSTIC FIBR SLY DISEASE &GENE THER$225,543

P41 · FY2002 · RR

DEVELOP 13C NMR SPECTROSCOPIC METHODS TO STUDY CANCER$225,543

P41 · FY2002 · RR

NMR PREDICTION AND MONITORING OF RADIATION RESPONSE$172,208

R01 · FY2002 · CA

IN VIVO NMR OF TUMORS AND THEIR RESPONSE TO CHEMOTHERAPY$156,493

R01 · FY2002 · CA

SMALL ANIMAL MULTI-MODALITY IMAGING CENTER (SAMMIC)$547,922

R24 · FY2001 · CA

NMR PREDICTION AND MONITORING OF RADIATION RESPONSE$400,410

R01 · FY2001 · CA

MID-ATLANTIC IN VIVO CELLULAR &MOLECULAR IMAGING CENTER$400,000

P20 · FY2001 · CA

IN VIVO NMR OF TUMORS AND THEIR RESPONSE TO CHEMOTHERAPY$364,938

R01 · FY2001 · CA

DEVELOP 13C NMR SPECTROSCOPIC METHODS TO STUDY CANCER$225,543

P41 · FY2001 · RR

MRS TO MONITOR GLUCURONIDASE ACTIVITY IN CYSTIC FIBR SLY DISEASE &GENE THER$225,543

P41 · FY2001 · RR

USE OF NMR TO MEASURE TUMOR AND NORMAL TISSUE METAB DURING TUMOR ACIDIFICATION$0

P01 · FY2001 · CA

SMALL ANIMAL MULTI-MODALITY IMAGING CENTER (SAMMIC)$533,546

R24 · FY2000 · CA

9.4T NMR SPECTROMETER/IMAGER UPGRADE$499,000

S10 · FY2000 · RR

MID ATLANTIC IN VIVO CELLULAR &MOLECULAR IMAGING CENTER$400,000

P20 · FY2000 · CA

NMR PREDICTION AND MONITORING OF RADIATION RESPONSE$219,252

R01 · FY2000 · CA

IN VIVO NMR OF TUMORS AND THEIR RESPONSE TO CHEMOTHERAPY$200,057

R01 · FY2000 · CA

USE OF NMR TO MEASURE TUMOR AND NORMAL TISSUE METAB DURING TUMOR ACIDIFICATION$184,121

P01 · FY2000 · CA

NMR DETECTION OF 13C TEMOZOLOMIDE IN CANINE BRAIN TUMORS$147,385

R21 · FY2000 · CA

MRS TO MONITOR GLUCURONIDASE ACTIVITY IN CYSTIC FIBR SLY DISEASE &GENE THER$28,012

P41 · FY2000 · RR

DEVELOP 13C NMR SPECTROSCOPIC METHODS TO STUDY CANCER$28,012

P41 · FY2000 · RR